Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Por um escritor misterioso
Descrição
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. - Abstract - Europe PMC
WO2014033122A1 - Inhibitors of cd40-traf6 interaction - Google Patents
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
Xichen Lin's research works China Academy of Building Research Shanghai Branch, Shanghai and other places
Kelly Dong's research works China FAW Group Corpration R&D Center, Jilin and other places
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride
Chan–Lam Reaction and Lewis Acid Promoted 1,3-Rearrangement of N–O Bonds to Prepare N-(2-Hydroxyaryl)pyridin-2-ones
Chan–Lam Reaction and Lewis Acid Promoted 1,3-Rearrangement of N–O Bonds to Prepare N-(2-Hydroxyaryl)pyridin-2-ones
Scholarly article on 2-hydroxy-6-(((4-methoxybenzyl)oxy)methyl)benzaldehyde 1035402-44-8 from Organic Letters p. 4936 - 4939
Directing the Metabolism of Drugs Away from CYP450: The Use of Oxetane Rings
WO2014033122A1 - Inhibitors of cd40-traf6 interaction - Google Patents
PDF) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
de
por adulto (o preço varia de acordo com o tamanho do grupo)